Resultados de la búsqueda 261-270 of 4652 for EBV

1. Cirugía - Ensayos clínicos - Mayo Clinic

   Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

2. Cirugía - Ensayos clínicos - Mayo Clinic

   Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

3. Hematología - Ensayos clínicos - Mayo Clinic

   Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

4. Cirugía - Ensayos clínicos - Mayo Clinic

   Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and docetaxel ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the registry will be to support ongoing ...

8. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this registry is to collect and maintain samples of breast tissue from women and men undergoing surgery for a breast related concern at Mayo ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...